but this is hardly new data. its just the same stuff dressed up a bit different and its not powered for statistical significance either.
Again, not saying that if the right people designed the right trial that the drug wouldnt work - just saying that this is poor for 4 months of work and where is the money coming from for this proposal
Ann: Dimerix Plans for Next Study in Diabetic Kidney Disease, page-5
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $217.2M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 40.5¢ | 37.0¢ | $813.2K | 2.102M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 142774 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 94053 | 5 |
View Market Depth
| Last trade - 14.55pm 08/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |